Profile
| Metric | Value |
|---|---|
| Full Name | PACS Group, Inc. |
| Ticker | NYSE: PACS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pacs.com |
| Employees | 32,433 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $41.36 | |
| Price, 1D Change | +0.44% | |
| Market Cap | $6B | |
| - | ||
| PE Ratio | 39.88 | |
| Beta | 0.64 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +31.44% | |
| EPS | $0.36 | |
| EPS, 1Y Change | -92.16% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.36 | |
| EPS Estimate | $1.85 | |
| EPS Est. Change | +415.11% | |
| Revenue | $4.09B | |
| Revenue Estimate | $5.31B | |
| Revenue Est. Change | +29.93% | |
| Current Price | $41.36 | |
| Price Target | - | $44.00 |
| Price Tgt. Change | - | +6.38% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.44 | $0.36 | -75.05% | |
| $1.85 | N/A | +415.11% | |
| $2.04 | N/A | +467.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.94B | $4.09B | +3.87% | |
| $5.31B | N/A | +29.93% | |
| $5.72B | N/A | +39.95% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +213.33% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +213.33% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +31.44% | |
| Revenue, 3Y | +250.58% | |
| EPS, 1Y | -92.16% | |
| EPS, 3Y | -81.53% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $41.36 | |
| SMA 200 | $15.29 | |
| SMA 200 vs Price | -63.03% | |
| SMA 50 | $27.21 | |
| SMA 50 vs Price | -34.21% | |
| Beta | 0.64 | |
| ATR | $1.72 | |
| 14-Day RSI | 83.90 | |
| 10-Day Volatility | 24.58% | |
| 1-Year Volatility | 98.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $33.72M | |
| Payout Ratio | 60.93% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.09B | |
| EPS | $0.36 | |
| Gross Profit | $466.88M | |
| Gross Margin | 11.42% | |
| Operating Profit | $125.58M | |
| Operating Margin | 3.07% | |
| Net Income | $55.34M | |
| Net Margin | 1.35% | |
| EBITDA | $166.39M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 5.11 | |
| Current Ratio | 0.96 | |
| Quick Ratio | 0.96 | |
| Interest Coverage | - | |
| 6 | ||
| Altman Z-Score | 1.47 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 39.88 | |
| PS Ratio | 1.25 | |
| PB Ratio | 7.37 | |
| EV/EBITDA | 28.45 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $709.55M | |
| Cash & Equivalents | $160.84M | |
| Total Assets | $6.12B | |
| Current Assets | $938.26M | |
| Total Liabilities | $5.41B | |
| Current Liabilities | $978.43M | |
| Total Debt | $3.63B | |
| Short Term Debt | $314.26M | |
| Accounts Payable | $175.06M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $4.03B | |
| Operating Expenses | $341.30M | |
| Cost Of Goods Sold | $3.62B | |
| SG&A | $0.00 | |
| D&A | $40.81M | |
| Interest Expense | $0.00 | |
| Income Tax | $46.21M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $367.34M | |
| CFI | -$442.18M | |
| CFF | $116.97M | |
| Capex | $66.47M | |
| Free Cash Flow | $300.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| Truist Securities | → | |
| Macquarie | → | |
| JP Morgan | → | |
| Stephens & Co. | → | |
| Truist Securities | → | |
| UBS | ||
| Truist Securities | → | |
| Stephens & Co. | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with PACS
Data Sources & References
- PACS Official Website pacs.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2001184/000200118425000071/0002001184-25-000071-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2001184/000200118425000068/0002001184-25-000068-index.htm
- PACS Profile on Yahoo Finance finance.yahoo.com/quote/PACS
- PACS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pacs
FAQ
What is the ticker symbol for PACS Group, Inc.?
The ticker symbol for PACS Group, Inc. is NYSE:PACS
Does PACS Group, Inc. pay dividends?
No, PACS Group, Inc. does not pay dividends
What sector is PACS Group, Inc. in?
PACS Group, Inc. is in the Healthcare sector
What industry is PACS Group, Inc. in?
PACS Group, Inc. is in the Medical Care Facilities industry
What country is PACS Group, Inc. based in?
PACS Group, Inc. is headquartered in United States
When did PACS Group, Inc. go public?
PACS Group, Inc. initial public offering (IPO) was on April 11, 2024
Is PACS Group, Inc. in the S&P 500?
No, PACS Group, Inc. is not included in the S&P 500 index
Is PACS Group, Inc. in the NASDAQ 100?
No, PACS Group, Inc. is not included in the NASDAQ 100 index
Is PACS Group, Inc. in the Dow Jones?
No, PACS Group, Inc. is not included in the Dow Jones index
When was PACS Group, Inc. last earnings report?
PACS Group, Inc.'s most recent earnings report was on November 19, 2025
When does PACS Group, Inc. report earnings?
The next expected earnings date for PACS Group, Inc. is March 30, 2026
